Severe paronychia due to zidovudine-induced neutropenia in a neonate - 07/09/11
Abstract |
We describe the case of an HIV-perinatally exposed child who was treated with zidovudine prophylaxis for reduction of perinatal transmission. At 4 weeks of age, he developed severe paronychia of the great toes as a result of Candida albicans and Escherichia coli . At that time, laboratory tests showed anemia and neutropenia. Zidovudine-related hematologic toxicity resolved after completion of the prophylactic regimen and the infant became HIV-antibody negative (seroreverter) at 8 months of age. Paronychia resolved after treatment with oral fluconazole and topical antiseptics but the soft tissue of the nailfold was penetrated by the edge of the nail plate, resulting in the formation of a cutaneous bridge over the nail that resolved by spontaneous necrosis. To our knowledge, this rare complication has not previously been described in an HIV-perinatally exposed child treated with zidovudine. (J Am Acad Dermatol 1999;40:322-4.)
Le texte complet de cet article est disponible en PDF.Plan
 | This supplement is made possible through an educational grant from Ortho Dermatological to the American Academy of Dermatology. |
| Reprint requests: Francisco Russo, MD, Plaza Neda 1, 1D, 11201, Algeciras, Spain. E-mail address: frussod@meditex.es |
 | 0190-9622/99/$8.00 + 0 16/4/94760 |
Vol 40 - N° 2S
P. 322-324 - février 1999 Retour au numéro
Article précédent
- Phakomatosis pigmentovascularis type IIa
- Nathalie Mandt, Ulrike Blume-Peytavi, Christine Pfrommer, Sven Krengel, Sergij Goerdt
- Cutaneous metastases from a chondroblastoma initially presenting as unilateral palmar hyperhidrosis
- MAJ Peter C. Seline, MAJ David J. Jaskierny
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?